Your browser doesn't support javascript.
loading
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
Reis, Rafael; Labat, Laurence; Allard, Marie; Boudou-Rouquette, Pascaline; Chapron, Jeanne; Bellesoeur, Audrey; Thomas-Schoemann, Audrey; Arrondeau, Jennifer; Giraud, Frédérique; Alexandre, Jérôme; Vidal, Michel; Goldwasser, François; Blanchet, Benoît.
Afiliação
  • Reis R; Pharmacokinetics and Pharmacochemistry Unit, CERIA, Cochin Hospital, APHP, Paris Descartes, CARPEM, 75014, Paris, France. Electronic address: rafael.reis@aphp.fr.
  • Labat L; Pharmacokinetics and Pharmacochemistry Unit, CERIA, Cochin Hospital, APHP, Paris Descartes, CARPEM, 75014, Paris, France; Inserm UMR - S1144, University of Paris Descartes - Paris Diderot, France.
  • Allard M; Pharmacokinetics and Pharmacochemistry Unit, CERIA, Cochin Hospital, APHP, Paris Descartes, CARPEM, 75014, Paris, France.
  • Boudou-Rouquette P; Oncology Unit, CERIA, Cochin Hospital, APHP, University of Paris Descartes, CARPEM, 75014, Paris, France.
  • Chapron J; Pneumology Unit, Cochin Hospital, APHP, 75014, Paris, France.
  • Bellesoeur A; Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, Cochin Hospital, APHP, 75014, Paris, France.
  • Thomas-Schoemann A; Multidisciplinary Risk Assessment and Drug Monitoring Unit, CERIA, Cochin Hospital, APHP, 75014, Paris, France; UMR8638 CNRS, Pharmacy UFR, University of Paris Descartes, PRES sorbonne Paris Cité, France.
  • Arrondeau J; Oncology Unit, CERIA, Cochin Hospital, APHP, University of Paris Descartes, CARPEM, 75014, Paris, France.
  • Giraud F; Pneumology Unit, Cochin Hospital, APHP, 75014, Paris, France.
  • Alexandre J; Oncology Unit, CERIA, Cochin Hospital, APHP, University of Paris Descartes, CARPEM, 75014, Paris, France.
  • Vidal M; Pharmacokinetics and Pharmacochemistry Unit, CERIA, Cochin Hospital, APHP, Paris Descartes, CARPEM, 75014, Paris, France; UMR8638 CNRS, Pharmacy UFR, University of Paris Descartes, PRES sorbonne Paris Cité, France.
  • Goldwasser F; Oncology Unit, CERIA, Cochin Hospital, APHP, University of Paris Descartes, CARPEM, 75014, Paris, France.
  • Blanchet B; Pharmacokinetics and Pharmacochemistry Unit, CERIA, Cochin Hospital, APHP, Paris Descartes, CARPEM, 75014, Paris, France; UMR8638 CNRS, Pharmacy UFR, University of Paris Descartes, PRES sorbonne Paris Cité, France.
J Pharm Biomed Anal ; 158: 174-183, 2018 Sep 05.
Article em En | MEDLINE | ID: mdl-29883880
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2018 Tipo de documento: Article